EPTIS
BAM Logo

Suche einen Ringversuch (RV) in der Datenbank

Länder
Seite 1 von 3 (Treffer 1 bis 20 von 48)
ID
Land
Anbieter
Ringversuch
Zuletzt geändert
1009007 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva] Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva] 2023-01-31
Prüfeigenschaft (Molecular Biology - Coronavirus (SARS-CoV2): saliva)
Ringversuchsbezeichnung (in Landessprache) (EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva)
Ringversuchsbezeichnung (Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva)

1050992 France CTCB CTCB RNA SARS-CoV2 (virology) [ARN SARS-CoV2 (virologie)] RNA SARS-CoV2 (virology) [ARN SARS-CoV2 (virologie)] 2023-05-24
Prüfeigenschaft (ARN SARS-CoV2 - cell culture supernatant)
Prüfobjekt (Detection of SARS-CoV2 RNA)
Ringversuchsbezeichnung (in Landessprache) (ARN SARS-CoV2 (virologie))
Ringversuchsbezeichnung (RNA SARS-CoV2 (virology))

1051761 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Sequencing: Coronavirus (SARS-CoV2) [EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)] Clinical PT - Sequencing: Coronavirus (SARS-CoV2) [EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)] 2023-05-29
Ringversuchsbezeichnung (in Landessprache) (EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2))
Ringversuchsbezeichnung (Clinical PT - Sequencing: Coronavirus (SARS-CoV2))

1083473 Brazil METROCERT METROCERT P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone [P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular] P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone [P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular] 2023-10-19
Prüfeigenschaft (Specific Absorption Rate (SAR))
Ringversuchsbezeichnung (in Landessprache) (P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular)
Ringversuchsbezeichnung (P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone)

1129430 Spain ielab ielab SARS-CoV-2 [SARS-CoV-2] SARS-CoV-2 [SARS-CoV-2] 2023-11-29
Prüfeigenschaft (SARS-CoV-2)
Ringversuchsbezeichnung (in Landessprache) (SARS-CoV-2)
Ringversuchsbezeichnung (SARS-CoV-2)

1138638 Canada CMPT - Canadian Microbiology Proficiency Testing CMPT - Canadian Microbiology Proficiency Testing COVID-19 COVID-19 2024-01-23
Prüfeigenschaft (SARS CoV-2)
Ringversuchsbezeichnung (COVID-19)

1144039 United Kingdom Weqas Weqas POCT Respiratory Virus [POCT Respiratory Virus] POCT Respiratory Virus [POCT Respiratory Virus] 2024-10-01
Kommentar (targeted for Influenza A (and subtypes) Influenza B, SARS-Cov-2, and Respiratory Syncytial Virus) (), influenza B, RSV, SARS-Cov-2 or no virus. A range of differing viral loads are distributed including) (reporting for SARS-CoV-2 Ag (RNA), Influenza A, Influenza B and RSV available. For more information)
Prüfeigenschaft (SARS-CoV-2 Ag (RNA))

1160040 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Antigen Detection – SARS-CoV-2 (Ag) (410) [Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)] Virus Antigen Detection – SARS-CoV-2 (Ag) (410) [Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)] 2024-04-16
Kommentar (samples with antigen from SARS-CoV-2 (inactivated) and, if necessary, samples with antigen from human) (immunoassays for the detection of SARS-CoV-2 antigen. The interdisciplinary, non-profit)
Prüfeigenschaft (SARS-CoV-2 antigen)
Ringversuchsbezeichnung (in Landessprache) (Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410))
Ringversuchsbezeichnung (Virus Antigen Detection – SARS-CoV-2 (Ag) (410))

1163304 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)] Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)] 2024-04-16
Prüfeigenschaft (incl. avian influenza A viruses, parecho, parainfluenza, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated), respectively)

1163321 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] 2024-04-16
Prüfeigenschaft (influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated))

1163338 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] 2024-04-16
Prüfeigenschaft (The sample set contains defined samples with SARS-CoV-2 (full virus, inactivated) and, if necessary) (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV-2)
Ringversuchsbezeichnung (in Landessprache) (Virusgenom-Nachweis - SARS-CoV-2 (409))
Ringversuchsbezeichnung (Virus Genome Detection – SARS-CoV-2 (409))

1163345 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – SARS-CoV-2 sequence analysis (417) [Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)] Virus Genome Detection – SARS-CoV-2 sequence analysis (417) [Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)] 2024-04-16
Kommentar (Please note: Starting in 2024, only results of SARS-CoV-2 sequence analyses for SARS-CoV-2)
Prüfeigenschaft (Differentiation of SARS-CoV-2 variants with clinical relevance using whole genome sequencing)
Ringversuchsbezeichnung (in Landessprache) (Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417))
Ringversuchsbezeichnung (Virus Genome Detection – SARS-CoV-2 sequence analysis (417))

1169419 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Immunology – SARS-CoV-2 (Ab) (416) [Virusimmunologie - SARS-CoV-2 (Ak) (416)] Virus Immunology – SARS-CoV-2 (Ab) (416) [Virusimmunologie - SARS-CoV-2 (Ak) (416)] 2024-05-14
Prüfeigenschaft (Anti-SARS-CoV-2 total (without differentiation of IgG, IgA and IgM)) (Anti-SARS-CoV-2 IgG) (Anti-SARS-CoV-2 IgG avidity) (Anti-SARS-CoV-2 IgA) (Anti-SARS-CoV-2 IgM (not certified))
Ringversuchsbezeichnung (in Landessprache) (Virusimmunologie - SARS-CoV-2 (Ak) (416))
Ringversuchsbezeichnung (Virus Immunology – SARS-CoV-2 (Ab) (416))

1217643 United Kingdom UK NEQAS for Microbiology UK NEQAS for Microbiology Respiratory viruses Point of Care [Respiratory viruses Point of Care] Respiratory viruses Point of Care [Respiratory viruses Point of Care] 2024-09-24
Prüfeigenschaft (Detection of antigens /nucleic acid for SARS-CoV-2, influenza and RSV using POCT devices)

1271426 Hungary QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. Virus nucleic acid determination: SARS-CoV-2 [Vírus nukleinsav meghatározás: SARS-CoV-2] Virus nucleic acid determination: SARS-CoV-2 [Vírus nukleinsav meghatározás: SARS-CoV-2] 2024-11-25
Kommentar (amplification techniques (NAT) for qualitative determination of SARS-CoV-2 virus. Qualitative results are)
Ringversuchsbezeichnung (in Landessprache) (Vírus nukleinsav meghatározás: SARS-CoV-2)
Ringversuchsbezeichnung (Virus nucleic acid determination: SARS-CoV-2)

1271523 Hungary QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. POCT: SARS-CoV-2 [POCT: SARS-CoV-2] POCT: SARS-CoV-2 [POCT: SARS-CoV-2] 2024-10-08
Kommentar (The content of the scheme: SARS-CoV-2 antibody (IgG, IgM, total antibody) and antigen determination)
Prüfeigenschaft (Anti-SARS-CoV-2 total qualitative) (Anti-SARS-CoV-2 - IgG qualitative) (Anti-SARS-CoV-2 - IgM qualitative) (SARS-CoV-2 Antigen qualitative) (SARS-CoV-2 interpretation)
Ringversuchsbezeichnung (in Landessprache) (POCT: SARS-CoV-2)
Ringversuchsbezeichnung (POCT: SARS-CoV-2)

1271562 Hungary QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. Virus serology: SARS-CoV-2 [Vírus szerológia: SARS-CoV-2] Virus serology: SARS-CoV-2 [Vírus szerológia: SARS-CoV-2] 2024-10-08
Kommentar (The content of the scheme: SARS-CoV-2 antibody (IgG-, IgG-S, IgG-N, IgM, IgA, total antibody)
Prüfeigenschaft (Anti-SARS-CoV-2 total (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-S (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-N (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgM (OD, S/CO, quantitative, evaluation))
Ringversuchsbezeichnung (in Landessprache) (Vírus szerológia: SARS-CoV-2)
Ringversuchsbezeichnung (Virus serology: SARS-CoV-2)

134427 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Water Microbiology Scheme - (QWAS) Water Microbiology Scheme - (QWAS) 2021-03-01
Prüfeigenschaft (SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial))
Prüfmethode (2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix)

1347466 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - POCT Respiratory Infections Panel [EP Clínico - POCT Painel para Infecções Respiratórias] Clinical PT - POCT Respiratory Infections Panel [EP Clínico - POCT Painel para Infecções Respiratórias] 2025-03-24
Prüfeigenschaft (Coronavirus (SARS-CoV2): nasopharynx and oropharynx)

138199 United States Collaborative Testing Services Collaborative Testing Services CTS Agriculture Laboratory Proficiency (ALP) Program: Water CTS Agriculture Laboratory Proficiency (ALP) Program: Water 2024-07-18
Prüfeigenschaft (Sum Cations, SAR, ADJ-SAR)

Seite 1 von 3 (Treffer 1 bis 20 von 48)
Haben Sie Fragen? Senden Sie uns eine E-Mail: eptis@bam.de.
Anwendungsversion: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5